REVIEW OF NICE'S TECHNOLOGY APPRAISAL RECOMMENDATIONS

被引：0
|
作者：
Rinaldi, F. [1 ]
George, E. [1 ]
Longson, C. [1 ]
机构：
[1] Natl Inst Hlth & Clin Excellence, London, England
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.704
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A317 / A318
页数：2
相关论文
共 50 条
  • [31] Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
    Rose, Micah
    Shepherd, Jonathan
    Harris, Petra
    Pickett, Karen
    Lord, Joanne
    PHARMACOECONOMICS, 2018, 36 (11) : 1299 - 1308
  • [32] OPTIMIZED RECOMMENDATIONS IN NICE TECHNOLOGY APPRAISALS: PERMISSIVE OR RESTRICTIVE?
    Maslyankov, I
    Bajela, E.
    King, M.
    Tang, S.
    VALUE IN HEALTH, 2023, 26 (12) : S357 - S357
  • [33] WHO review committee makes NICE recommendations
    McLellan, F
    LANCET, 2003, 362 (9388): : 966 - 966
  • [34] The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual
    Angelis, Aris
    Harker, Martin
    Cairns, John
    Seo, Mikyung Kelly
    Legood, Rosa
    Miners, Alec
    Wiseman, Virginia
    Chalkidou, Kalipso
    Grieve, Richard
    Briggs, Andrew
    VALUE IN HEALTH, 2023, 26 (10) : 1503 - 1509
  • [35] All health is not equal: the use of modifiers in NICE technology appraisal
    Charlton, Victoria
    BMJ EVIDENCE-BASED MEDICINE, 2023, 28 (04) : 247 - 250
  • [36] Bevacizumab for Metastatic Colorectal CancerA NICE Single Technology Appraisal
    Sophie Whyte
    Abdullah Pandor
    Matt Stevenson
    PharmacoEconomics, 2012, 30 : 1119 - 1132
  • [37] Bevacizumab for Metastatic Colorectal Cancer A NICE Single Technology Appraisal
    Whyte, Sophie
    Pandor, Abdullah
    Stevenson, Matt
    PHARMACOECONOMICS, 2012, 30 (12) : 1119 - 1132
  • [38] Golimumab for the Treatment of Psoriatic Arthritis A NICE Single Technology Appraisal
    Yang, Huiqin
    Craig, Dawn
    Epstein, David
    Bojke, Laura
    Light, Kate
    Bruce, Ian N.
    Sculpher, Mark
    Woolacott, Nerys
    PHARMACOECONOMICS, 2012, 30 (04) : 257 - 270
  • [39] THE IMPACT OF THE DISEASE SEVERITY MODIFIER ON NICE TECHNOLOGY APPRAISAL DECISIONS
    Lee, J.
    Doran, R.
    VALUE IN HEALTH, 2023, 26 (12) : S375 - S375
  • [40] NICE Guide to the Methods of Technology Appraisal - Pharmaceutical industry perspective
    Earnshaw, Julia
    Lewis, Gavin
    PHARMACOECONOMICS, 2008, 26 (09) : 725 - 727
12345